Home

NANCY ANN DEPARLE

CIK 1144511 · last filed 2026-04-30

NANCY ANN DEPARLE is a corporate insider who has filed 52 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for HCA, was dated Apr 30, 2026. Current disclosed insider exposure totals $14.0M across reported positions. 31 SEC filings were submitted jointly with DAVITA INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$14.04M

Companies

7

Total Filings

52

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
CERNER CORP
2800 ROCKCREEK PKWY
KANSAS CITY, MO 64117-2551
Related Filers
DAVITA INC. — 31 joint filings, latest 2008-07-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HCA Director 21,910 $405.00 $8.87M $0 13 2026-04-30
CVS Director 34,169 $96.74 $3.31M $0 23 2024-11-25
MEDCO HEALTH SOLUTIONS INC (MHS) Delisted Director — — — $0 1 2008-10-23
DVA Director 6,512 $183.99 $1.20M $0 10 2008-07-02
CERNER Corp (CERN) Delisted Director 64,000 $94.92 $6.07M $0 2 2008-05-28
BSX Director 13,886 $47.80 $663.8K $0 2 2008-05-08
TRI Director 0 $105.68 $0 $0 1 2007-07-25

Recent Filings

52 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-04-30 HCA Grant (A) +509 $0 EDGAR
2025-05-01 HCA Grant (A) +645 $0 EDGAR
2024-11-25 CVS Grant (A) +2,331 $133.1K EDGAR
2024-05-17 CVS Grant (A) +2,314 $133.1K EDGAR
2024-05-01 HCA Grant (A) +610 $0 EDGAR
2023-11-17 CVS Grant (A) +1,925 $133.1K EDGAR
2023-05-19 CVS Grant (A) +1,437 $99.6K EDGAR
2023-04-26 HCA Grant (A) +663 $0 EDGAR
2022-11-21 CVS Grant (A) +1,402 $133.1K EDGAR
2022-05-13 CVS Grant (A) +1,358 $133.1K EDGAR
Showing 1–10 of 52
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.